The Chairman and CEO, the founder of AstaTech (USA) and AstaTech (Chengdu) Biopharmaceutical Corp. Mr. Paul Guo got his B.S. from the Department of Chemistry, Sichuan University, M.S. in Organic Synthesis from Dalian Institute of Chemical Physics, Chinese Academy of Sciences and M.S. from the University of Manitoba, Canada. He worked for Sterling Winthrop, Sanofi-Aventis Pharmaceutical Corp. and Bristol-Myers Squibb in Drug Discovery Department in U.S.

Mr. Paul Guo has published 18 papers and applied for 59 patents.

Dr. Chris Hugh Senanayake has served as the Global Vice President of Chemical Process Development in a World’s Top 500 pharmaceutical enterprise. Dr. Chris Hugh Senanayake has nearly 30 years experience in the pharmaceutical industry. He worked as Senior Executives at internationally renowned enterprises including Dow Chemical, Merck, Sepacor Inc. and Boehringer Ingelheim. He led the development of six new drug projects such as Crixivan. He has published 354 papers and applied for 100 patents. He is a famous scientist in the international pharmaceutical industry and has been awarded “Expert of the Sichuan Provincial Hundred-talent Program” and “Distinguished Expert of Sichuan Province”.